Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2015 | 10-2014 | 10-2013 | 10-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -2,305 | -2,521 | -1,965 | N/A |
| Depreciation Amortization | 401 | 715 | 700 | N/A |
| Accounts receivable | -84 | -58 | -43 | N/A |
| Other Working Capital | -96 | 20 | 14 | N/A |
| Other Operating Activity | 339 | 279 | 112 | 0 |
| Operating Cash Flow | $-1,745 | $-1,565 | $-1,182 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -4 | N/A | -17 | N/A |
| Sale Of Investment | 201 | 1,629 | -540 | N/A |
| Purchase Sale Intangibles | -66 | -112 | -44 | N/A |
| Other Investing Activity | -66 | -112 | -43 | 0 |
| Investing Cash Flow | $131 | $1,517 | $-600 | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 1,472 | 223 | 1,965 | N/A |
| Other Financing Activity | -61 | 0 | -165 | 0 |
| Financing Cash Flow | $1,411 | $223 | $1,800 | $N/A |
| Beginning Cash Position | 374 | 251 | 251 | N/A |
| End Cash Position | 171 | 426 | 269 | N/A |
| Net Cash Flow | $-203 | $175 | $18 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -1,745 | -1,565 | -1,182 | N/A |
| Capital Expenditure | -4 | N/A | -17 | N/A |
| Free Cash Flow | -1,749 | -1,565 | -1,199 | 0 |